ProFund Advisors »

Revance Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $401k 35k 11.47
2023-06-30 $471k 19k 25.31
2023-03-31 $548k 17k 32.21
2021-06-30 $205k 6.9k 29.52
2018-09-30 $277k 11k 24.86